Hypertension Clinical Trials

Showing 3241-3260 of 3,518 trials

Renal Denervation in Patients With Uncontrolled Hypertension in Chinese

NCT01390831

The purpose of this study is to determine whether renal denervation is safe and effective in the treatment of Chinese patients with uncontrolled hypertension.

Hypertension

The Second People's Hospital of Chengdu100 participantsStarted Nov 2011

COMPLETEDNA

Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation

NCT01390701

The purpose of this study is to compare the blood pressure reducing property of transcutaneous electrical nerve stimulation with the blood pressure reducing drug felodipin.

Hypertension

Sahlgrenska University Hospital41 participantsStarted Jan 2008

Gothenburg, Sweden

COMPLETEDPhase 4

Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

NCT00237588

To determine if angiotensin-II AT-1 receptor blockade(ARB) may improve insulin sensitivity assessed by the hyperinsulinaemic isoglycaemic glucose clamp, more than CCB therapy at a comparable dose with regards to the blood pressure-lowering effect.

Hypertension

Ullevaal University Hospital25 participantsStarted Dec 2004

Oslo, Norway

COMPLETEDNA

Risk Assessment and Treat Compliance in Hypertension Education Trial

NCT00694239

The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.

HypertensionDyslipidemia

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's100 participantsStarted May 2007

London, Ontario, Canada

Renal Denervation in Patients With Uncontrolled Hypertension in Chinese

Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation

Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

Risk Assessment and Treat Compliance in Hypertension Education Trial

Related Searches

Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study

Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study

Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease

Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.

Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)

Travoprost Five Day Posology Study

Accuracy of Non-Invasive Blood Pressure Measurement in Adults

The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM

Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Blood Pressure and Glucose Lowering Diet for Taiwanese

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments